bioRxiv Science⌕ Search

Biology subjects

Lipson, L. D.

Publications and source records attributed to Lipson, L. D..

2 recordsLinked to original sources

Indigenous gut microbes modulate neural cell state and neurodegenerative disease susceptibility

The native microbiome influences a plethora of host processes, including neurological function. However, its impacts on diverse brain cell types remains poorly understood. Here, we performed single nucleus RNA sequencing on hippocampi from wildtype, germ-free mice and reveal the microbiome-dependent transcriptional landscape across all major neural cell types. We found conserved impacts on key adaptive immune and neurodegenerative transcriptional pathways, underscoring the microbiomes contributions to disease-relevant processes. Mono-colonization with select indigenous microbes identified species-specific effects on the transcriptional state of brain myeloid cells. Colonization by Escherichia coli induced a distinct adaptive immune and neurogenerative disease-associated cell state, suggesting increased disease susceptibility. Indeed, E. coli exposure in the 5xFAD mouse model resulted in exacerbated cognitive decline and amyloid pathology, demonstrating its sufficiency to worsen Alzheimers disease-relevant outcomes. Together, these results emphasize the broad, species-specific, microbiome-dependent consequences on neurological transcriptional state and highlight the capacity of specific microbes to modulate disease susceptibility. HighlightsO_LIThe microbiome impacts the transcriptional landscape of all major brain cell types. C_LIO_LIDiscrete microbes specifically modulate resident myeloid cell status. C_LIO_LIGut E. coli triggers dynamic transcriptional responses across neural cell types. C_LIO_LIExposure to E. coli exacerbates behavioral and cellular pathologies in 5xFAD mice. C_LI

neuroscience↗

APP-KI mice do not display the hallmark age-dependent cognitive decline of amyloid diseases

APP knock-in (KI) mice serve as an exciting new model system to understand amyloid beta (A{beta}) pathology, overcoming many of the limitations of previous overexpression-based model systems. The APPSAA mouse model (containing the humanized APP with three familial Alzheimers disease mutations) and the APPWT control are the first commercially available APP KI mice within the United States. While APPSAA mice have been shown to develop progressive A{beta} pathology and neuroinflammation, behavioral changes, particularly in cognitive functions, have yet to be described. Therefore, we performed an in-depth longitudinal study over 12 months, assessing cognition in these two strains, as well as assessments of motor and GI function. We surprisingly note no overt, progressive cognitive impairment or motor deficits. However, we do observe a significant increase in fecal output in APPSAA mice compared to APPWT at 12 months old. These data provide a baseline for these models behavioral attributes. HighlightsO_LIAPPSAA and APPWT knock-in mice do not display age related cognitive decline C_LIO_LIFecal output appears altered by APP genotype, but no other measure of GI function is impacted. C_LIO_LIBoth genotypes behave equally in motor function tests C_LI

neuroscience↗